Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies.
J Biol Chem. 2006 Apr 21;281(16):10706-14. doi: 10.1074/jbc.M513415200. Epub 2006 Feb 15.
J Biol Chem. 2006.
PMID: 16481314
Free article.
Single variable domain antibody as a versatile building block for the construction of IgG-like bispecific antibodies.
Shen J, Vil MD, Jimenez X, Zhang H, Iacolina M, Mangalampalli V, Balderes P, Ludwig DL, Zhu Z.
Shen J, et al. Among authors: iacolina m.
J Immunol Methods. 2007 Jan 10;318(1-2):65-74. doi: 10.1016/j.jim.2006.09.020. Epub 2006 Oct 26.
J Immunol Methods. 2007.
PMID: 17126853
Item in Clipboard
An antibody directed against PDGF receptor beta enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody.
Shen J, Vil MD, Zhang H, Tonra JR, Rong LL, Damoci C, Prewett M, Deevi DS, Kearney J, Surguladze D, Jimenez X, Iacolina M, Bassi R, Zhou K, Balderes P, Mangalampalli VR, Loizos N, Ludwig DL, Zhu Z.
Shen J, et al. Among authors: iacolina m.
Biochem Biophys Res Commun. 2007 Jun 15;357(4):1142-7. doi: 10.1016/j.bbrc.2007.04.075. Epub 2007 Apr 19.
Biochem Biophys Res Commun. 2007.
PMID: 17462601
Item in Clipboard
Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody.
Shen J, Vil MD, Prewett M, Damoci C, Zhang H, Li H, Jimenez X, Deevi DS, Iacolina M, Kayas A, Bassi R, Persaud K, Rohoza-Asandi A, Balderes P, Loizos N, Ludwig DL, Tonra J, Witte L, Zhu Z.
Shen J, et al. Among authors: iacolina m.
Neoplasia. 2009 Jun;11(6):594-604. doi: 10.1593/neo.09278.
Neoplasia. 2009.
PMID: 19484148
Free PMC article.
Item in Clipboard
Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation.
Paz K, Brennan LA, Iacolina M, Doody J, Hadari YR, Zhu Z.
Paz K, et al. Among authors: iacolina m.
Mol Cancer Ther. 2005 Nov;4(11):1801-9. doi: 10.1158/1535-7163.MCT-05-0174.
Mol Cancer Ther. 2005.
PMID: 16276002
Item in Clipboard
Pleiotropic stromal effects of vascular endothelial growth factor receptor 2 antibody therapy in renal cell carcinoma models.
Duignan IJ, Corcoran E, Pennello A, Plym MJ, Amatulli M, Claros N, Iacolina M, Youssoufian H, Witte L, Samakoglu S, Schwartz J, Surguladze D, Tonra JR.
Duignan IJ, et al. Among authors: iacolina m.
Neoplasia. 2011 Jan;13(1):49-59. doi: 10.1593/neo.101162.
Neoplasia. 2011.
PMID: 21245940
Free PMC article.
Item in Clipboard
Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab Resistance.
Bagchi A, Haidar JN, Eastman SW, Vieth M, Topper M, Iacolina MD, Walker JM, Forest A, Shen Y, Novosiadly RD, Ferguson KM.
Bagchi A, et al. Among authors: iacolina md.
Mol Cancer Ther. 2018 Feb;17(2):521-531. doi: 10.1158/1535-7163.MCT-17-0575. Epub 2017 Nov 20.
Mol Cancer Ther. 2018.
PMID: 29158469
Free PMC article.
Item in Clipboard
Automation of steroid radioimmunoassays using a robotics workstation.
Antonian L, Iacolina MD, Proulx RR.
Antonian L, et al. Among authors: iacolina md.
Clin Lab Sci. 1995 Mar-Apr;8(2):117-20.
Clin Lab Sci. 1995.
PMID: 10150469
Item in Clipboard
Cite
Cite